Latest News & Features
Americas
An Ontario-based company has sued Allergan for allegedly infringing a method patent that protects the use of cosmetic drug Botox to treat back pain. 20 April 2015
Big Pharma
Law firm Schiff Hardin has added a life sciences specialist as a partner in its intellectual property group. 17 April 2015
Americas
A product of decomposing leaf litter, exDNA could be a powerful tool for interacting with biological systems. If so, the IP associated with its applications may be an active area in the coming years, says non-practising barrister Charles Brabin. 16 April 2015
Americas
The US Court of Appeals for the Second Circuit has heard arguments surrounding whether Actavis should be allowed to discontinue its first Alzheimer’s drug Namenda to make way for an extended release version of the medicine. 16 April 2015
Americas
The US Patent Trial and Appeal Board has instigated an interference proceeding between Biogen and Forward Pharma to determine who first invented a treatment for multiple sclerosis. 15 April 2015
Americas
Israeli pharmaceutical company Teva has, in one single filing, accused five generic drug makers of infringing a patent covering its blockbuster multiple sclerosis drug Copaxone. 14 April 2015
Americas
The US Court of Appeals for the Federal Circuit has upheld the validity of four patents covering conjunctivitis treatment AzaSite. 14 April 2015
Americas
The US House of Representatives Judiciary Committee will hold a hearing on the Innovation Act tomorrow, during which testaments will be given by representatives from Eli Lilly and the Biotechnology Industry Organization. 13 April 2015
Americas
Dallas-based hedge fund Hayman Capital Management has defended its owner’s decision to challenge a clutch of patents using the inter partes review procedure. 13 April 2015
Americas
Patent and trademark attorney firm Murgitroyd has boosted its intellectual property team by promoting Michael Marchant to director. 10 April 2015